Clinical potential of phycocyanobilin for induction of T regulatory cells in the management of inflammatory disorders

Medical Hypotheses

Volumn 77, Issue 6, 2011, Pages 1031-1033

  McCarty, Mark F ^a  

^a NutriGuard Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BILIVERDIN; HEME OXYGENASE 1; IMMUNOMODULATING AGENT; INTERLEUKIN 10; OXIDOREDUCTASE INHIBITOR; PHYCOCYANOBILIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SPIRULINA EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; CELL ACTIVITY; ENZYME ACTIVITY; ENZYME INDUCTION; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATORY DISEASE; MACROPHAGE; MULTIPLE SCLEROSIS; NONHUMAN; REGULATORY T LYMPHOCYTE;

AUTOIMMUNE DISEASES; HUMANS; HYPERSENSITIVITY; LEUKOCYTES, MONONUCLEAR; PHYCOBILINS; PHYCOCYANIN; SPIRULINA; T-LYMPHOCYTES, REGULATORY;

MUS; RODENTIA; SPIRULINA;

EID: 80855132772     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.08.041     Document Type: Article

References (53)

1. Penton-Rol G, Martinez-Sanchez G, Cervantes-Llanos M, Lagumersindez-Denis N, costa-Medina EF, Falcon-Cama V, onso-Ramirez R, et.al. C-Phycocyanin ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells. Int Immunopharmacol 2010 October 21.
2. Choi B.M., Pae H.O., Jeong Y.R., Kim Y.M., Chung H.T. Critical role of heme oxygenase-1 in Foxp3-mediated immune suppression. Biochem Biophys Res Commun 2005 February 25, 327(4):1066-1071.
3. Xia Z.W., Zhong W.W., Xu L.Q., Sun J.L., Shen Q.X., Wang J.G., et al. Heme oxygenase-1-mediated CD4+CD25high regulatory T cells suppress allergic airway inflammation. J Immunol 2006 November 1, 177(9):5936-5945.
4. Xia Z.W., Xu L.Q., Zhong W.W., Wei J.J., Li N.L., Shao J. Heme oxygenase-1 attenuates ovalbumin-induced airway inflammation by up-regulation of foxp3 T-regulatory cells, interleukin-10, and membrane-bound transforming growth factor- 1. Am J Pathol 2007 December, 171(6):1904-1914.
5. Hu A.P., Du J.M., Li J.Y., Liu J.W. Oridonin promotes CD4+/CD25+ Treg differentiation, modulates Th1/Th2 balance and induces HO-1 in rat splenic lymphocytes. Inflamm Res 2008 April, 57(4):163-170.
6. Majewska M., Zajac K., Dulak J., Szczepanik M. Heme oxygenase (HO-1) is involved in the negative regulation of contact sensitivity reaction. Pharmacol Rep 2008 November, 60(6):933-940.
7. Zhong W., Xia Z., Hinrichs D., Rosenbaum J.T., Wegmann K.W., Meyrowitz J., et al. Hemin exerts multiple protective mechanisms and attenuates dextran sulfate sodium-induced colitis. J Pediatr Gastroenterol Nutr 2010 February, 50(2):132-139.
8. Yamashita K., Ollinger R., McDaid J., Sakahama H., Wang H., Tyagi S., et al. Heme oxygenase-1 is essential for and promotes tolerance to transplanted organs. FASEB J 2006 April, 20(6):776-778.
9. McCarty M.F. Clinical potential of Spirulina as a source of phycocyanobilin. J Med Food 2007 December, 10(4):566-570.
10. Rocuts F., Zhang X., Yan J., Yue Y., Thomas M., Bach F.H., et al. Bilirubin promotes de novo generation of T regulatory cells. Cell Transplant 2010, 19(4):443-451.
11. Liu Y., Zhu B., Luo L., Li P., Paty D.W., Cynader M.S. Heme oxygenase-1 plays an important protective role in experimental autoimmune encephalomyelitis. Neuroreport 2001 July3, 12(9):1841-1845.
12. Liu Y., Zhu B., Wang X., Luo L., Li P., Paty D.W., et al. Bilirubin as a potent antioxidant suppresses experimental autoimmune encephalomyelitis: implications for the role of oxidative stress in the development of multiple sclerosis. J Neuroimmunol 2003 June, 139(1-2):27-35.
13. Liu Y., Li P., Lu J., Xiong W., Oger J., Tetzlaff W., et al. Bilirubin possesses powerful immunomodulatory activity and suppresses experimental autoimmune encephalomyelitis. J Immunol 2008 August 1, 181(3):1887-1897.
14. Terry M.J., Maines M.D., Lagarias J.C. Inactivation of phytochrome- and phycobiliprotein-chromophore precursors by rat liver biliverdin reductase. J Biol Chem 1993 December15, 268(35):26099-26106.
15. Lanone S., Bloc S., Foresti R., Almolki A., Taille C., Callebert J., et al. Bilirubin decreases nos2 expression via inhibition of NAD(P)H oxidase: implications for protection against endotoxic shock in rats. FASEB J 2005 November, 19(13):1890-1892.
16. Matsumoto H., Ishikawa K., Itabe H., Maruyama Y. Carbon monoxide and bilirubin from heme oxygenase-1 suppresses reactive oxygen species generation and plasminogen activator inhibitor-1 induction. Mol Cell Biochem 2006 October, 291(1-2):21-28.
17. Jiang F., Roberts S.J., Datla S., Dusting G.J. NO modulates NADPH oxidase function via heme oxygenase-1 in human endothelial cells. Hypertension 2006 November, 48(5):950-957.
18. Datla S.R., Dusting G.J., Mori T.A., Taylor C.J., Croft K.D., Jiang F. Induction of heme oxygenase-1 in vivo suppresses NADPH oxidase derived oxidative stress. Hypertension 2007 October, 50(4):636-642.
19. Kraaij M.D., Savage N.D., van der Kooij S.W., Koekkoek K., Wang J., van den Berg J.M., et al. Induction of regulatory T cells by macrophages is dependent on production of reactive oxygen species. Proc Natl Acad Sci U S A 2010 October 12, 107(41):17686-17691.
20. Hultqvist M., Backlund J., Bauer K., Gelderman K.A., Holmdahl R. Lack of reactive oxygen species breaks T cell tolerance to collagen type II and allows development of arthritis in mice. J Immunol 2007 August 1, 179(3):1431-1437.
21. Hultqvist M., Olsson L.M., Gelderman K.A., Holmdahl R. The protective role of ROS in autoimmune disease. Trends Immunol 2009 May, 30(5):201-208.
22. Sareila O, Kelkka T, Pizzolla A, Hultqvist M, Holmdahl R. NOX2 complex derived ROS as immune regulators. Antioxid Redox Signal 2010. October 4.
23. Kapitulnik J., Maines M.D. Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin. Trends Pharmacol Sci 2009 March, 30(3):129-137.
24. Wegiel B., Baty C.J., Gallo D., Csizmadia E., Scott J.R., Akhavan A., et al. Cell surface biliverdin reductase mediates biliverdin-induced anti-inflammatory effects via phosphatidylinositol 3-kinase and Akt. J Biol Chem 2009 August 7, 284(32):21369-21378.
25. Khattar M., Chen W., Stepkowski S.M. Expanding and converting regulatory T cells: a horizon for immunotherapy. Arch Immunol Ther Exp (Warsz) 2009 May, 57(3):199-204.
26. Heo Y.J., Joo Y.B., Oh H.J., Park M.K., Heo Y.M., Cho M.L., et al. IL-10 suppresses Th17 cells and promotes regulatory T cells in the CD4+ T cell population of rheumatoid arthritis patients. Immunol Lett 2010 January 4, 127(2):150-156.
27. Tamion F., Richard V., Renet S., Thuillez C. Protective effects of heme-oxygenase expression against endotoxic shock: inhibition of tumor necrosis factor-alpha and augmentation of interleukin-10. J Trauma 2006 November, 61(5):1078-1084.
28. Ma J.L., Yang P.Y., Rui Y.C., Lu L., Kang H., Zhang J. Hemin modulates cytokine expressions in macrophage-derived foam cells via heme oxygenase-1 induction. J Pharmacol Sci 2007 March, 103(3):261-266.
29. Umeda K., Takahashi T., Inoue K., Shimizu H., Maeda S., Morimatsu H., et al. Prevention of hemorrhagic shock-induced intestinal tissue injury by glutamine via heme oxygenase-1 induction. Shock 2009 January, 31(1):40-49.
30. Ma L.J., You Y., Bai B.X., Li Y.Z. Therapeutic effects of heme oxygenase-1 on psoriasiform skin lesions in guinea pigs. Arch Dermatol Res 2009 July, 301(6):459-466.
31. Sierra-Filardi E., Vega M.A., Sanchez-Mateos P., Corbi A.L., Puig-Kroger A. Heme Oxygenase-1 expression in M-CSF-polarized M2 macrophages contributes to LPS-induced IL-10 release. Immunobiology 2010 September, 215(9-10):788-795.
32. Visner G.A., Lu F., Zhou H., Latham C., Agarwal A., Zander D.S. Graft protective effects of heme oxygenase 1 in mouse tracheal transplant-related obliterative bronchiolitis. Transplantation 2003 August 27, 76(4):650-656.
33. Sarady-Andrews J.K., Liu F., Gallo D., Nakao A., Overhaus M., Ollinger R., et al. Biliverdin administration protects against endotoxin-induced acute lung injury in rats. Am J Physiol Lung Cell Mol Physiol 2005 December, 289(6):L1131-L1137.
34. Overhaus M., Moore B.A., Barbato J.E., Behrendt F.F., Doering J.G., Bauer A.J. Biliverdin protects against polymicrobial sepsis by modulating inflammatory mediators. Am J Physiol Gastrointest Liver Physiol 2006 April, 290(4):G695-G703.
35. Drechsler Y., Dolganiuc A., Norkina O., Romics L., Li W., Kodys K., et al. Heme oxygenase-1 mediates the anti-inflammatory effects of acute alcohol on IL-10 induction involving p38 MAPK activation in monocytes. J Immunol 2006 August 15, 177(4):2592-2600.
36. OGAWA Y., Duru E.A., Ameredes B.T. Role of IL-10 in the resolution of airway inflammation. Curr Mol Med 2008 August, 8(5):437-445.
37. Mosser D.M., Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev 2008 December, 226:205-218.
38. Hedrich C.M., Bream J.H. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol Res 2010 July, 47(1-3):185-206.
39. Jung M., Sabat R., Kratzschmar J., Seidel H., Wolk K., Schonbein C., et al. Expression profiling of IL-10-regulated genes in human monocytes and peripheral blood mononuclear cells from psoriatic patients during IL-10 therapy. Eur J Immunol 2004 February, 34(2):481-493.
40. Chen S., Kapturczak M.H., Wasserfall C., Glushakova O.Y., Campbell-Thompson M., Deshane J.S., et al. Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway. Proc Natl Acad Sci U S A 2005 May 17, 102(20):7251-7256.
41. Koch N., Jung M., Sabat R., Kratzschmar J., Docke W.D., Asadullah K., et al. IL-10 protects monocytes and macrophages from complement-mediated lysis. J Leukoc Biol 2009 July, 86(1):155-166.
42. Li J.Q., Qi H.Z., He Z.J., Hu W., Si Z.Z., Li Y.N., et al. Cytoprotective effects of human interleukin-10 gene transfer against necrosis and apoptosis induced by hepatic cold ischemia/reperfusion injury. J Surg Res 2009 November, 157(1):e71-e78.
43. Mandal P., Park P.H., McMullen M.R., Pratt B.T., Nagy L.E. The anti-inflammatory effects of adiponectin are mediated via a heme oxygenase-1-dependent pathway in rat Kupffer cells. Hepatology 2010 April, 51(4):1420-1429.
44. Romay C., Gonzalez R., Ledon N., Remirez D., Rimbau V. C-phycocyanin: a biliprotein with antioxidant, anti-inflammatory and neuroprotective effects. Curr Protein Pept Sci 2003 June, 4(3):207-216.
45. Fritzsching E., Kunz P., Maurer B., Poschl J., Fritzsching B. Regulatory T cells and tolerance induction. Clin Transplant 2009 December, 23(Suppl 21):10-14.
46. Palomares O., Yaman G., Azkur A.K., Akkoc T., Akdis M., Akdis C.A. Role of Treg in immune regulation of allergic diseases. Eur J Immunol 2010 May, 40(5):1232-1240.
47. Fujio K., Okamura T., Yamamoto K. The Family of IL-10-secreting CD4+ T cells. Adv Immunol 2010, 105:99-130.
48. Hanidziar D., Koulmanda M. Inflammation and the balance of Treg and Th17 cells in transplant rejection and tolerance. Curr Opin Organ Transplant 2010 August, 15(4):411-415.
49. Balachandran P., Pugh N.D., Ma G., Pasco D.S. Toll-like receptor 2-dependent activation of monocytes by Spirulina polysaccharide and its immune enhancing action in mice. Int Immunopharmacol 2006 December 5, 6(12):1808-1814.
50. Romay C., Delgado R., Remirez D., Gonzalez R., Rojas A. Effects of phycocyanin extract on tumor necrosis factor-alpha and nitrite levels in serum of mice treated with endotoxin. Arzneimittelforschung 2001 September, 51(9):733-736.
51. McCarty M.F., Barroso-Aranda J., Contreras F. Practical strategies for targeting NF-kappaB and NADPH oxidase may improve survival during lethal influenza epidemics. Med Hypotheses 2010 January, 74(1):18-20.
52. McCarty M.F., Barroso-Aranda J., Contreras F. A two-phase strategy for treatment of oxidant-dependent cancers. Med Hypotheses 2007, 69(3):489-496.
53. Ghiringhelli F., Menard C., Puig P.E., Ladoire S., Roux S., Martin F., et al. Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients. Cancer Immunol Immunother 2007 May, 56(5):641-648.